Enriched cancer pathway | Genes under regulation | P value |
ECM.receptor interaction |
9 genes: COL1A2, COL5A1, ITGA6, ITGA5, ITGAV, SDC2, THBS1, SDC3, SV2B
|
5.442e-05 |
Neurotrophin signaling pathway |
11 genes: SH2B3, IRAK3, JUN, NTRK2, NTRK3, RAP1A, RAP1B, YWHAH, CALM3, CAMK2A, IRS2
|
5.451e-05 |
Focal adhesion |
12 genes: COL1A2, COL5A1, PIP5K1C, ITGA6, ITGA5, ITGAV, JUN, PPP1R12A, PTEN, RAP1A, RAP1B, THBS1
|
0.0007942 |
Hippo signaling pathway |
10 genes: LATS2, LATS1, DLG2, TEAD1, SMAD7, SMAD4, BMPR2, WNT9A, FZD4, YWHAH
|
0.001179 |
Cell adhesion molecules .CAMs. |
9 genes: CNTN1, CADM1, NEGR1, ITGA6, ITGAV, NEO1, CLDN11, SDC2, SDC3
|
0.0018 |
Salivary secretion |
7 genes: ADCY5, ADCY9, ITPR1, ATP2B4, RYR3, VAMP2, CALM3
|
0.002167 |
Oocyte meiosis |
8 genes: ADCY5, ADCY9, ITPR1, CPEB1, YWHAH, CALM3, CAMK2A, CDC27
|
0.002213 |
Adipocytokine signaling pathway |
6 genes: CAMKK2, CPT1A, ACACB, PPARA, PRKAB2, IRS2
|
0.002494 |
Long.term potentiation |
6 genes: ITPR1, PPP1R12A, RAP1A, RAP1B, CALM3, CAMK2A
|
0.002889 |
Calcium signaling pathway |
10 genes: ADCY9, ITPR1, ATP2A2, ATP2B4, PTGER3, PTGFR, RYR3, CALM3, CAMK2A, CACNA1H
|
0.003285 |
Melanogenesis |
7 genes: ADCY5, ADCY9, MITF, WNT9A, CALM3, CAMK2A, FZD4
|
0.004407 |
Pancreatic secretion |
7 genes: ADCY5, ADCY9, ITPR1, ATP2A2, ATP2B4, RAP1A, RAP1B
|
0.004407 |
Glycosaminoglycan biosynthesis . chondroitin sulfate |
3 genes: CHSY3, CHST7, XYLT1
|
0.009473 |
Dorso.ventral axis formation |
3 genes: NOTCH1, FMN2, CPEB1
|
0.01353 |
GnRH signaling pathway |
6 genes: ADCY5, ADCY9, ITPR1, JUN, CALM3, CAMK2A
|
0.01664 |
Gastric acid secretion |
5 genes: ADCY5, ADCY9, ITPR1, CALM3, CAMK2A
|
0.01694 |
Phosphatidylinositol signaling system |
5 genes: DGKB, PIP5K1C, ITPR1, PTEN, CALM3
|
0.02082 |
Regulation of actin cytoskeleton |
9 genes: CFL2, IQGAP2, FGF2, PIP5K1C, ITGA6, ITGA5, ITGAV, MYH9, PPP1R12A
|
0.03034 |
Wnt signaling pathway |
7 genes: DAAM1, JUN, SMAD4, TBL1X, WNT9A, CAMK2A, FZD4
|
0.03394 |